title: Hypertension associated with angiogoenesis inhibitors: what do oncologists really do in daily routine? A small survey.
authors: Umut
authors: U
authors: Dişel
authors: Hüseyin
authors: H
authors: Abalı
authors: Ahmet Taner
authors: AT
authors: Sümbül
authors: Ozgür
authors: O
authors: Ozyılkan
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D000068258:Bevacizumab; D001795:Blood Pressure Determination; D018660:Blood Pressure Monitoring, Ambulatory; D003625:Data Collection; D006801:Humans; D006973:Hypertension / Q000139:chemically induced* / Q000175:diagnosis* / Q000188:drug therapy; D008495:Medical Oncology; D009369:Neoplasms / Q000188:drug therapy*; D009819:Office Visits; D010818:Practice Patterns, Physicians'; D011795:Surveys and Questionnaires; D014421:Turkey
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000959:Antihypertensive Agents; D000068258:Bevacizumab